NDC11 70692013914
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 70692-0139-14 | 70692-0139 |
| 70692-139-14 | 70692-139 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cetirizine hydrochloride | CETIRIZINE HYDROCHLORIDE | Strive Pharmaceuticals Inc | a4ebeec7-0245-4f77-e053-2995a90a7e7f | 2020-11-17 | Warnings | 70692-139-14 70692-139 70692013914 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.